User profiles for "author:Jan Marsal"
Jan MarsalLund University Verified email at med.lu.se Cited by 3514 |
[PDF][PDF] IRF4 transcription-factor-dependent CD103+ CD11b+ dendritic cells drive mucosal T helper 17 cell differentiation
EK Persson, H Uronen-Hansson, M Semmrich… - Immunity, 2013 - cell.com
Summary CD103+ CD11b+ dendritic cells (DCs) represent the major migratory DC
population within the small intestinal lamina propria (SI-LP), but their in vivo function …
population within the small intestinal lamina propria (SI-LP), but their in vivo function …
Mucosal T lymphocyte numbers are selectively reduced in integrin αE (CD103)-deficient mice
MP Schön, A Arya, EA Murphy, CM Adams… - The Journal of …, 1999 - journals.aai.org
The mucosal lymphocyte integrin α E (CD103) β 7 is thought to be important for
intraepithelial lymphocyte (IEL) localization or function. We cloned the murine integrin gene …
intraepithelial lymphocyte (IEL) localization or function. We cloned the murine integrin gene …
[HTML][HTML] Effects of vedolizumab therapy on extraintestinal manifestations in inflammatory bowel disease
M Fleisher, J Marsal, SD Lee, LE Frado… - Digestive diseases and …, 2018 - Springer
Abstract Background Approximately 15–20% of ulcerative colitis patients and 20–40% of
those with Crohn's disease experience extraintestinal manifestations (EIMs) of their …
those with Crohn's disease experience extraintestinal manifestations (EIMs) of their …
[HTML][HTML] CCL25 mediates the localization of recently activated CD8αβ+ lymphocytes to the small-intestinal mucosa
M Svensson, J Marsal, A Ericsson… - The Journal of …, 2002 - Am Soc Clin Investig
The recruitment of antigen-specific T lymphocytes to the intestinal mucosa is central to the
development of an effective mucosal immune response, yet the mechanism by which this …
development of an effective mucosal immune response, yet the mechanism by which this …
Targeting T‐cell migration in inflammatory bowel disease
Crohn's disease and ulcerative colitis are chronic inflammatory disorders of the
gastrointestinal tract and are collectively referred to as inflammatory bowel disease (IBD) …
gastrointestinal tract and are collectively referred to as inflammatory bowel disease (IBD) …
[HTML][HTML] Management of non-response and loss of response to anti-tumor necrosis factor therapy in inflammatory bowel disease
J Marsal, M Barreiro-de Acosta, I Blumenstein… - Frontiers in …, 2022 - frontiersin.org
Anti-TNF therapy has been successfully used as first-line biologic treatment for moderate-to-
severe inflammatory bowel disease (IBD), in both 'step-up'and 'top-down'approaches, and …
severe inflammatory bowel disease (IBD), in both 'step-up'and 'top-down'approaches, and …
[HTML][HTML] Vedolizumab treatment for immune checkpoint inhibitor-induced enterocolitis
V Bergqvist, E Hertervig, P Gedeon, M Kopljar… - Cancer Immunology …, 2017 - Springer
Immune checkpoint inhibitors (ICPI), such as ipilimumab [anti-cytotoxic T-lymphocyte
antigen-4 (CTLA-4) antibody] and nivolumab or pembrolizumab [anti-programmed cell death …
antigen-4 (CTLA-4) antibody] and nivolumab or pembrolizumab [anti-programmed cell death …
Gut-associated lymphoid tissue–primed CD4+ T cells display CCR9-dependent and -independent homing to the small intestine
H Stenstad, A Ericsson, B Johansson-Lindbom… - Blood, 2006 - ashpublications.org
CD4+ T-cell entry to the intestinal mucosa is central to the generation of mucosal immunity
as well as chronic intestinal inflammation, yet the mechanisms regulating this process …
as well as chronic intestinal inflammation, yet the mechanisms regulating this process …
Long-term effectiveness of vedolizumab in inflammatory bowel disease: a national study based on the Swedish National Quality Registry for Inflammatory Bowel …
C Eriksson, J Marsal, D Bergemalm… - Scandinavian journal …, 2017 - Taylor & Francis
Objectives: Clinical trials have demonstrated the efficacy of vedolizumab in inflammatory
bowel disease (IBD). However, these findings may not reflect the clinical practice. Therefore …
bowel disease (IBD). However, these findings may not reflect the clinical practice. Therefore …
[HTML][HTML] Severe intestinal dysbiosis is prevalent in primary Sjögren's syndrome and is associated with systemic disease activity
Background Altered microbial composition of the intestine, commonly referred to as
dysbiosis, has been associated with several autoimmune diseases including primary …
dysbiosis, has been associated with several autoimmune diseases including primary …